GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » HPC Biosciences Ltd (BOM:535217) » Definitions » Capex-to-Operating-Income

HPC Biosciences (BOM:535217) Capex-to-Operating-Income : 0.00 (As of Mar. 2023)


View and export this data going back to 2013. Start your Free Trial

What is HPC Biosciences Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

HPC Biosciences's Capital Expenditure for the six months ended in Mar. 2023 was ₹0.00 Mil. Its Operating Income for the six months ended in Mar. 2023 was ₹-2.44 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


HPC Biosciences Capex-to-Operating-Income Historical Data

The historical data trend for HPC Biosciences's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HPC Biosciences Capex-to-Operating-Income Chart

HPC Biosciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

HPC Biosciences Semi-Annual Data
Sep13 Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of HPC Biosciences's Capex-to-Operating-Income

For the Farm Products subindustry, HPC Biosciences's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HPC Biosciences's Capex-to-Operating-Income Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, HPC Biosciences's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where HPC Biosciences's Capex-to-Operating-Income falls into.



HPC Biosciences Capex-to-Operating-Income Calculation

HPC Biosciences's Capex-to-Operating-Income for the fiscal year that ended in Mar. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -5.237
=N/A

HPC Biosciences's Capex-to-Operating-Income for the quarter that ended in Mar. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -2.439
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HPC Biosciences  (BOM:535217) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


HPC Biosciences Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of HPC Biosciences's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


HPC Biosciences (BOM:535217) Business Description

Traded in Other Exchanges
N/A
Address
Plot Number 22, Pooja Complex, Office Number 109, First Floor, Veer Savarkar Block, Shakarpur, Delhi, IND, 110092
HPC Biosciences Ltd is an Indian-based company that operates in the agricultural industry. The business activity of the group includes producing and marketing agricultural products, including wheat, rice, pulses, and vegetables. Geographically operations are performed through the regions of India, and it derives revenue from the sale of products.

HPC Biosciences (BOM:535217) Headlines

No Headlines